Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
SLRN
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13D/A
Filing time
23 May 2025, 16:15:26 UTC
Date of event
21 May 2025
Previous filing
12 Mar 2025

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 0% ownership in Acelyrin, Inc. Common Stock, par value $0.00001 per share (SLRN) on 21 May 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Acelyrin, Inc. Common Stock, par value $0.00001 per share (SLRN).
  • Disclosed ownership: 0%.
  • Date of event: 21 May 2025.

What Changed

  • Previous schedule filing date: 12 Mar 2025.
  • Current filing was accepted on 23 May 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 0% 0 0 0 /s/ Kevin Tang Manager 0001232621
KEVIN TANG 0% 0 0 0 /s/ Kevin Tang Self 0001178579
TANG CAPITAL PARTNERS, LP 0% 0 0 0 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0001191935
TANG CAPITAL PARTNERS INTERNATIONAL, LP 0% 0 0 0 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0002064011
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0002036763
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0002036770
CONCENTRA BIOSCIENCES, LLC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0001970065